YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection

Hepatology

Volumn 29, Issue 3, 1999, Pages 939-945

  Ono Nita, Suzane Kioko ^a   Kato, Naoya ^a   Shiratori, Yasushi ^a   Masaki, Tsutomu ^a   Lan, Keng Hsin ^a   Carrilho, Flair José ^b   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; DNA DIRECTED DNA POLYMERASE; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; METHIONINE; VIRUS DNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE MUTATION; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HYDROPHOBICITY; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS REPLICATION;

EID: 0033017849     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290340     Document Type: Article

References (9)

1. World Health Organization warns of growing "crisis of suffering." http://www.who.ch/whr/1997/presse.htm.
2. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991;324:1699-1704.
3. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997:336:347-356.
4. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Destky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993;119:312-323.
5. Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982;29:403-415.
6. Schinazi RF, Chu CK, Peck A, McMillan A, Mattis R, Cannon D, Jeong LS, et al. Activities of the four optical isomers of 2′, 3′-dideoxi-3′-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes. Antimicrob Agents Chemother 1992;36:672-676.
7. Chang C-N, Doong S-L, Zhou JH, Beach JW, Jeong LS, Chu CK, Tsai C-H, et al. Deoxycytidine deaminase-resistant stereoisomer is the active form of (±)-2′,3′-dideoxi-3′-thiacytidine in the inhibition of hepatitis B virus replication. J Biol Chem 1992;267:13938-13942.
8. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B virus infection. N Engl J Med 1995;333:1657-1661.
9. Benhamou Y, Katlama C, Lunel E. Coutellier A, Dohin E, Hamm N, Tubiana R, et al. Effect of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med 1996:125:705-712.